Skip to main content
Download PDF

Simultaneous production of DHA and squalene from Aurantiochytrium sp. grown on forest biomass hydrolysates

Biotechnology for Biofuels volume 12, Article number: 255 (2019) Cite this article

Abstract

Background

Recent evidence points to the nutritional importance of docosahexaenoic acid (DHA) in the human diet. Thraustochytrids are heterotrophic marine oleaginous microorganisms capable of synthesizing high amounts of DHA, as well as other nutraceutical compounds such as squalene, in their cellular compartment. Squalene is a natural triterpene and an important biosynthetic precursor to all human steroids. It has a wide range of applications in the cosmetic and pharmaceutical industries, with benefits that include boosting immunity and antioxidant activity. Apart from its nutritional quality, it can also be utilized for high-grade bio-jet fuel by catalytic conversion.

Results

In the present study, the potential of thraustochytrid strain Aurantiochytrium sp. T66 to produce DHA and squalene was evaluated. When the strain was cultivated on organosolv-pretreated birch hydrolysate (30 g/L glucose) in flask, it resulted in 10.39 g/L of cell dry weight and 4.98 g/L of total lipids, of which 25.98% was DHA. In contrast, when the strain was grown in a bioreactor, cell dry weight, total lipid, and DHA increased to 11.24 g/L, 5.90 g/L, and 35.76%, respectively. The maximum squalene yield was 69.31 mg/gCDW (0.72 g/L) when the strain was cultivated in flask, but it increased to 88.47 mg/gCDW (1.0 g/L), when cultivation shifted to a bioreactor.

Conclusions

This is the first report demonstrating the utilization of low cost non-edible lignocellulosic feedstock to cultivate the marine oleaginous microorganism Aurantiochytrium sp. for the production of nutraceutical vital compounds. Owing to the simultaneous generation of DHA and squalene, the strain is suitable for industrial-scale production of nutraceuticals.

Background

Algae-based renewable energy and chemicals have gained increasing attention over the past few decades, mostly due to their potential to lower greenhouse gas emissions and reduce our dependency on fossil fuels [1]. However, algae-based industries are still incapable of sustainable and cheap biofuel production, as external energy is required for upstream and downstream processing [2]. It has been argued that cost-effective production of biofuels from microalgae is possible only if it is integrated with co-production of value-added chemicals for the petrochemical or pharmaceutical industries [3]. Some microalgal species allow the co-production of value-added chemicals in the current biorefinery concept. Microalgae can be used for a variety of applications, such as renewable energy (bioethanol, biodiesel, and biogas), nutraceuticals (omega-3 and omega-6 fatty acids such as eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), docosahexaenoic acid (DHA), and functional proteins), pharmaceutical pigments (β-carotene, squalene, and astaxanthin), for food and cosmetics, fertilizers, and bioplastics [4]. This multiproduct paradigm makes them suitable for sustainable biorefinery concepts [3] and, particularly, the generation of high-value fatty acids.

Most naturally occurring fatty acids are composed of a 4–28 carbon atom unbranched chain; they can be saturated, monounsaturated, or polyunsaturated depending on the nature of the hydrocarbon chain [5]. The human body has the capacity to synthesize a variety of saturated and unsaturated fatty acids, but cannot synthesize some polyunsaturated fatty acids (PUFAs), such as omega-3 and omega-6 fatty acids, due to the lack of certain elongases (Elovl2 or Elovl5) and delta-6-desaturases (FADS2) [6]. However, the human body can synthesize the parent omega-3 fatty acids (α-linolenic acid; ALA) and omega-6 fatty acids (linoleic acid; LA) [7]. Although a small amount of LA can be converted to dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA), and a minimal amount of ALA can be converted to EPA and DHA, this is not nearly enough to cover the daily intake of 0.30–0.45 g EPA and DHA required by a male adult [8]. Hence, food-based intake of these essential fatty acids is paramount. Nowadays, the main source of PUFAs is fish belonging to the Salmonidae, Scombridae, and Clupeidae families, as they contain high levels of DHA and EPA [8]. Unfortunately, the rising demand for these fatty acids cannot be met solely by fish oil, because it is becoming increasingly environmentally unsustainable [9]. Other potential sources of PUFAs are vegetable oils and oleaginous microorganisms. Plants can employ the fatty acid synthase complex (desaturase enzyme) in plastids to synthesize certain PUFAs, such as oleic acid (18:1n9), LA (18:2n6), γ-LA (18:3n6), ALA (18:3n3), and octadecatetraenoic acid (18:4n3) [10]. However, plants cannot synthesize long-chain PUFAs as they lack separate desaturase/elongase enzymes [11]. Accordingly, elevated levels of long-chain omega-3 fatty acids, such as DPA, DHA, and EPA, can only be achieved with genetically engineered plants, such as Brassica juncea, Brassica napus, Glycine max, and Arabidopsis thaliana, following the introduction of desaturase/elongase genes [11, 12]. On the downside, plant cultivation is dependent on climate conditions and the availability of arable land. Importantly, the productivity of omega-3 fatty acids by plants is inferior to that achieved by oleaginous microorganisms [13]. Oleaginous microorganisms are natural producers of a diverse group of fatty acids, which vary depending on the chosen species and cultivation conditions [14]. Application of biochemical and genetic engineering techniques can further improve production of the desired compounds [15], which is important for the commercial production of microbial omega-3 fatty acids. The first known microbial strain for commercial γ-LA-rich oil production was the filamentous fungus Mucor circinelloides [16]. Several other microalgal species have been explored thereafter for commercial omega-3 PUFA production.

Microalgae such as diatoms are most commonly used for microbial production of DHA and EPA. The majority of diatoms can only grow photoautotrophically, which often hinders their commercialization due to low productivity. Heterotrophic growth, whereby microalgae grow on an organic carbon source such as glucose, can potentially increase PUFA productivity. To enable this, appropriate candidates capable of growth on organic carbon sources should be found. Thraustochytrids, a group of marine protists belonging to the Labyrinthula class of the Chromista Kingdom, can grow heterotrophically and can synthesize high amounts of DHA. These properties make them excellent candidates for commercial DHA production, with the Aurantiochytrium/Schizochytrium genera being of particular interest [17].

Most Thraustochytrids also possess significant quantities of natural antioxidants such as terpenoids, in their cellular compartment to protect omega-3 fatty acids from oxidative stress [18]. The most common terpenoid in Aurantiochytrium/Schizochytrium is squalene (2,6,10,15,19,23-hexamethyl-6,6,10,14,18,20-tetracosahexane), a polyunsaturated hydrocarbon triterpenoid [19]. Squalene is obtained mainly from the liver oil of deep-sea sharks and whales and acts as a precursor for the biosynthesis of bile acid, cholesterol, and steroids in animals and plants [20]. However, consumption of liver oil can pose a threat to our health, due to contamination with environmental pollutants, including heavy metals, mercury, and polychlorinated biphenyls along with a putrid odor and unpleasant taste [21, 22]. Moreover, the presence of chemically similar compounds such as cholesterol in liver oils can affect squalene purification. Squalene is used as a valuable ingredient in the cosmetic industry due to quenching of singlet oxygen (1O2) [23]. It is also used in the pharmaceutical industry, due to its positive effect on the immune response, the ability to reduce serum cholesterol levels and suppress tumor proliferation [24, 25], as well as an adjuvant to increase immune responsiveness to vaccines [26]. Squalene acts as a precursor of thousands of bioactive compounds, including sterols and hopanoids [27]. Another field of application of squalene is the production of high-grade bio-jet fuels by catalytic conversion. For example, in a study, the branched hydrocarbon of squalene was successfully converted into smaller hydrocarbon without skeletal isomerization and aromatization over ruthenium on ceria (Ru/CeO2) [28]. Similarly, pure squalene and squalene containing Botryococcus braunii liquid were utilized for bio-jet fuel production by Ru/CeO2 [29]. The global demand for squalene has been increasing over the past decade, amounting to around 2.67 kilotons in 2014 [30], and cannot be met solely by extracting it from the liver of marine animals; an approach that is severely affecting marine ecosystems. Only a handful of plant species are known to be capable of producing adequate quantities of squalene for pharmaceutical or nutraceutical industrial applications [31]. Instead, high-scale terpenoid production by marine microalgae suggests that thraustochytrids could serve also for large-scale commercial generation of squalene [32].

The present study evaluated the potential production of DHA and squalene by the marine thraustochytrid species Aurantiochytrium sp. T66 (ATCC PRA-276). Heterotrophic cultivation of Aurantiochytrium sp. was initially carried out on pure glucose and was then replaced by forest biomass hydrolysates (enzymatically saccharified organosolv-pretreated birch chips). To the best of our knowledge, this is the first report describing the use of forest biomass for the cultivation of a thraustochytrid species and the consequent co-production of DHA and squalene. The proposed strategy is promising for the commercial production of various value-added compounds.

Results and discussion

Batch cultivations of Aurantiochytrium sp. T66 in flask and bioreactor

Aurantiochytrium sp. is a heterotrophic unicellular marine thraustochytrid, closely related to heterokont algae and well known for its elevated DHA production [33]. It is ubiquitous in marine environments such as mangroves and mud flats, feeding mainly on organic substrates present in the environment [17]. It can grow on various types of sugars, but glucose is known to support high cell density along with high amounts of DHA [34]. It can tolerate high concentrations of carbon sources, including as much as 120 g/L of glucose [35]. In the present study, we evaluated the DHA and squalene biosynthetic ability of this strain during batch cultivation on glucose (30 g/L) derived from organosolv-pretreated birch hydrolysate (OPBH), both in flasks and bioreactors.

Growth on commercial glucose (30 g/L) in a flask was assessed first and compared with results on OPBH. Cell dry weight (CDW), lipid concentration, DHA content, and squalene concentration were similar between an OPBH-grown culture and those cultivated on pure glucose (Fig. 1), as can be expected given the absence of inhibitors in the hydrolysate [36]. Hybrid organosolv-steam explosion was used to treat the birch biomass, resulting in high-cellulose-containing solids (89%, w/w), which were enzymatically saccharified at 10% w/w solids content, yielding 77.07 g/L of glucose [37]. Yeast extract was used as nitrogen source (11.6% w/w total nitrogen). Yeast extract (containing 9–12% of total nitrogen) is usually obtained from spent yeast biomass of brewery industries and is commonly used for large-scale growth of thraustochytrid species including Aurantiochytrium sp. [38].

Fig. 1
figure1

Comparison of Aurantiochytrium sp. cultivated on pure glucose and OPBH. Growth and lipid production by Aurantiochytrium sp. T66 (ATCC PRA-276) grown in Erlenmeyer flasks on either pure glucose or OPBH containing 30 g/L of glucose

Full size image

Time-course results showing cell dry weight (g/L), total lipid concentration (g/L), lipid content (% w/w), and residual glucose (g/L) following growth of the microalga in flask or bioreactor are presented in Fig. 2. Both flask and bioreactor cultures were inoculated with a 2-day grown seed culture and 15 mL were harvested immediately after inoculation; this resulted in 0.19 ± 0.02 g/L cell dry weight at 0 h of cultivation. After 24 h, cell dry weight was 3.89 ± 0.13 g/L in flask and 5.67 ± 0.55 g/L in bioreactor cultures, with glucose consumption being 5.46 g/L and 11.68 g/L, respectively. The corresponding total lipid concentration was 0.77 ± 0.17 g/L and 1.23 ± 0.13 g/L (Fig. 2). The exponential phase of algal growth was reached within the first 8 h of cultivation, as observed by OD600 values (data not reported here). After 24 h, growth continued linearly until the stationary phase was reached at 96 h in flasks and 72 h in the bioreactor (Fig. 2). A similar growth profile had been observed with other species, such as Aurantiochytrium SW1 [39] and Aurantiochytrium sp. SD116 [40]. The highest cell dry weight for Aurantiochytrium sp. cultivated in flask (10.39 ± 0.73 g/L) was attained after 96 h, with the supplied glucose being almost completely consumed by that point (Fig. 2a). At the same time, maximum total lipid concentration was 4.98 ± 0.38 g/L, or 47.93% (w/w) of lipid content (Fig. 2a). In contrast, in the bioreactor, the highest cell dry weight (11.24 ± 0.79 g/L) was attained after 72 h of cultivation and no glucose was left in the medium at that point (Fig. 2b). The maximum lipid concentration in the bioreactor was 5.9 ± 0.43 g/L, or 52.49% (w/w) of lipid content (Fig. 2b). The observed lipid synthesis pattern was similar to that of other heterotrophically cultivated microalgae such as Crypthecodinium cohnii, and other thraustochytrids such as Schizochytrium sp. S31 [41, 42]. Both of these strains are also well studied for their DHA production [43]. In another study, strain Aurantiochytrium sp. ATCC PRA-276 generated 9.3 g/L of cell dry weight when cultivated on 30 g/L of glucose with 3 g/L of total nitrogen (1.36 g/L (NH4)2SO4, 13.63 g/L yeast extract, and 13.63 g/L monosodium glutamate), whereas a higher cell dry weight was observed when the strain was cultivated on 0.44 g/L of total nitrogen (0.2 g/L (NH4)2SO4, 2.0 g/L yeast extract, and 2.0 g/L monosodium glutamate) with the same amount of glucose [44]. Other thraustochytrid species such as Schizochytrium sp. S31 exhibited a similar pattern of glucose utilization, by utilizing all the glucose present in medium after 5 days [45]. Schizochytrium sp. S31 synthesized 6.01 g/L of biomass and 2.38 g/L of total lipids, corresponding to 39.60% w/w lipid content when cultivated in a flask at pH 7.0 with 20 g/L glucose and 4 g/L of yeast extract [45]. After reaching stationary phase, cell dry weight of Aurantiochytrium sp. declined slightly, mainly due to fewer lipids (Fig. 2). At this point, the cells were harvested; alternatively, the lipids could be utilized for further growth. Once they have exhausted all carbon sources from the medium, oleaginous microorganisms can utilize lipid reserves for growth and biomass production through β-oxidations of fatty acids [46]. Lipid degradation was observed also in Aurantiochytrium sp. 18 W-13a, in which lipids dropped drastically from 3.90 ± 0.22 to 1.53 ± 0.21 g/L between the 4th and 8th day of cultivation after glucose exhaustion [47]. The results of biomass and lipid formation yield are presented in Fig. 3. Maximum biomass and lipid formation yield of 0.35 g/gsubstrate and 0.17 g/gsubstrate, respectively, were obtained after 96 h of cultivation in flask (Fig. 3a). In bioreactors, higher biomass and lipid yield of 0.37 g/gsubstrate and 0.19 g/gsubstrate, respectively, were obtained at 72 h (Fig. 3b). Biomass productivity was 2.59 g/L/day and 3.74 g/L/h for cultures grown in flasks and bioreactor, respectively; while the corresponding lipid productivity was 1.25 g/L/day and 1.97 g/L/day (Table 1). The higher yield and productivity obtained in the bioreactor were likely a result of better pH regulation and oxygen transfer during growth [17].

Fig. 2
figure2

Batch cultivation of Aurantiochytrium sp. in flask and bioreactor. Time-course determination of cell dry weight (g/L), total lipid concentration (g/L), lipid content (%, w/w), and residual glucose (g/L) of Aurantiochytrium sp. T66 (ATCC PRA-276) cultivated on OPBH containing 30 g/L of glucose in a erlenmeyer flasks and b bioreactor

Full size image
Fig. 3
figure3

Estimation of biomass and lipid yield of Aurantiochytrium sp. cultivated in flask and bioreactor. Time-course determination of biomass yield (g/gsubstrate) and lipid yield (g/gsubstrate) of Aurantiochytrium sp. T66 (ATCC PRA-276) cultivated on OPBH containing 30 g/L of glucose in a erlenmeyer flasks and b bioreactor

Full size image
Table 1 Summary of various parameters relating to the cultivation of Aurantiochytrium sp. T66 on OPBH in flask and bioreactor
Full size table

Effect of cultivation conditions on DHA concentration of Aurantiochytrium sp.

The fatty acid profile of Aurantiochytrium sp. is presented in Fig. 4 and is similar to that of other thraustochytrids [48]: the main fatty acids were C14:0, C15:0, C16:0, C17:0, C18:0, and DHA, and their ratio changed with cultivation time. When this strain was cultivated to stationary phase (96 h) in a flask, the following amounts of lipids were synthesized: C14:0 (5.17%), C15:0 (9.21%), C16:0 (49.19%), C17:0 (3.60%), C18:0 (3.59%), and DHA (25.98%). When cultivated for 72 h in a bioreactor, the following amounts were synthesized: C14:0 (2.17%), C15:0 (9.00%), C16:0 (42.32%), C17:0 (4.08%), C18:0 (3.09%), and DHA (35.76%). Time-course experiment data regarding DHA concentration (g/L) and DHA content (%, w/w of total lipids) of Aurantiochytrium sp. cultivated in a flask and bioreactor are presented in Fig. 5a. Aurantiochytrium sp. synthesized 16.28% DHA (w/wtotal lipids) after 24 h of cultivation in a flask (Fig. 4a); the same amount was obtained after only 24 h in a bioreactor (16.56% w/wtotal lipids) and using OPBH as a substrate (Fig. 5b). When the algae were cultivated in flasks, the highest DHA content was 25.98% w/wtotal lipids after 96 h, corresponding to a DHA concentration of 1.29 g/L. Further extension of the growth period to 120 h resulted in reduced DHA content and concentration: 17.23% w/wtotal lipids and 0.89 g/L, respectively. When the algae were cultivated in a bioreactor, considerably higher DHA content and concentration were achieved at an earlier time (72 h): 35.76% w/wtotal lipids and 2.1 g/L, respectively (Fig. 5b). The high quantity of DHA in the bioreactor-grown culture resulted most likely from improved oxygen supply during growth as the conversion of saturated fatty acids into unsaturated fatty acids proceeds at higher rates when oleaginous microorganisms are grown under abundant oxygen [17]. DHA production by several thraustochytrids on different media is presented in Table 2. Optimized conditions lead to a high PUFA yield [49]. Thraustochytrium sp. ATCC 26185 previously showed enhanced DHA production, from 1.16 to 1.68 g/L, after optimization of various fermentation parameters, such as initial pH (6.89), inoculum volume (4.16%), and fermentation volume (140.47 mL) [50]. Moreover, cultivation of thraustochytrid strains in flasks resulted in significantly different levels of DHA production compared to bioreactor cultivation. For example, Thraustochytrium roseum exhibited enhanced growth in flasks compared to a stirred tank bioreactor, in which growth was inhibited due to high mechanical stirring [51]. In contrast, Schizochytrium sp. SR21 exhibited better growth in a bioreactor than in flasks because this strain was highly resistant to mechanical stirring [52]. Three species of Schizochytrium mangrovei (FB1, FB2, and FB3) cultivated on 20 g/L of glucose in a flask synthesized from 32.29 to 39.14% w/wtotal lipids of DHA, and only a slight difference in fatty acids composition (C14:0, C16:0, C22:5, and C22:6) was observed when the culture was harvested in either early or late stationary phase [53].

Fig. 4
figure4

Estimation of the fatty acid profile of Aurantiochytrium sp. Fatty acid profile (% w/wtotal lipid) of Aurantiochytrium sp. T66 (ATCC PRA-276) cultivated on OPBH containing 30 g/L of glucose in erlenmeyer flasks and bioreactor

Full size image
Fig. 5
figure5

Quantification of DHA in extracted lipids. Estimation of DHA concentration (g/L) and DHA content (%, w/wtotal llipids) of Aurantiochytrium sp. T66 (ATCC PRA-276) cultivated on OPBH containing 30 g/L of glucose in a erlenmeyer flasks and b bioreactor

Full size image
Table 2 Production of DHA by various marine thraustochytrids
Full size table

Extraction of squalene from Aurantiochytrium sp. cultivated in flask and bioreactor

The light orange color of the cultures indicated the presence of carotenoids, which have antioxidant activity, in the cells of Aurantiochytrium [54]. Squalene, astaxanthin, echinenone and lutein are the most important carotenoids present in Aurantiochytrium [17]. Squalene production by other Aurantiochytrium strains is presented in Table 3.

Table 3 Squalene production by various marine thraustochytrids
Full size table

Squalene is an intermediate of the cholesterol biosynthesis pathway and acts as a natural antioxidant to protect the cells form reactive oxygen species [24]. The qualitative evaluation of squalene in total lipids was carried out by thin-layer chromatography (TLC) and the chromatograms corresponding to flask and bioreactor-grown cultures are presented in Fig. 6a, b, respectively. Squalene concentration (g/L) and yield (mg/gCDW) of Aurantiochytrium sp. cultivated on OPBH in a flask or bioreactor are presented in Fig. 7a, b, respectively. Squalene concentration increased from 0.05 g/L (15.34 mg/gCDW) to 0.72 g/L (69.31 mg/gCDW) when algae were cultivated in flasks for 96 h instead of 24 h. Extending growth to 120 h had a negative impact on squalene concentration, which dropped to 0.44 g/L (43.35 mg/gCDW). This is likely due to increased synthesis of steryl ester (SE) from squalene once stationary phase was reached, as shown in the Fig. 6a, lane 6. During bioreactor cultivation, the concentration of squalene increased from 0.10 g/L (16.56 mg/gCDW) to 1.0 g/L (88.47 mg/gCDW) between 24 and 96 h. Squalene was clearly visible in the total lipid extract obtained from algae cultivated in a bioreactor for 24 h to 96 h (Fig. 6b, lanes 2 to 5). Squalene purification was carried out by fractionating total lipids into saponifiable and unsaponifiable fractions and was followed by TLC analysis. As shown in Fig. 6c, the unsaponifiable fraction presented a high amount of squalene (Fig. 6c, lane 1); whereas the saponifiable fraction presented only a minor yet easily detected amount (Fig. 6c, lane 2). Following saponification of total lipids, squalene was extracted from the total unsaponifiable lipids fraction with n-hexane as solvent. After solvent evaporation, the colorless liquid was identified by TLC (Fig. 6c, lane 3) using a squalene standard (Fig. 6c, lane 4). The squalene extracted from the unsaponifiable fraction was not 100% pure, as it contained a minor amount of triacylglycerol (TAG, Fig. 6c, line 3). Further purification can be achieved by fractional crystallization or other column chromatographic methods [31, 53].

Fig. 6
figure6

TLC analysis of extracted lipids from Aurantiochytrium sp. Analysis of squalene in total lipid extracts from Aurantiochytrium sp. T66 (ATCC PRA-276) cultivated on OPBH containing 30 g/L of glucose in a erlenmeyer flasks and b bioreactor. a Lane 1, squalene standard; lanes 2–6, samples cultivated for 24–120 h; lane 7, TAG standard. b Lane 1, squalene standard; lanes 2–5, samples cultivated for 24–96 h. c Purification of squalene from total lipid extracts following saponification: lane 1, unsaponifiable fraction; lane 2, saponified fraction; lane 3, purified product from unsaponifiable fraction; lane 4, squalene standard

Full size image
Fig. 7
figure7

Estimation of squalene concentration in extracted lipids from Aurantiochytrium sp. Evolution of squalene yield (mg/gCDW) and concentration (g/L) during cultivation of Aurantiochytrium sp. T66 (ATCC PRA-276) on OPBH containing 30 g/L of glucose in a erlenmeyer flasks and b bioreactor

Full size image

Nakazawa et al. [55] screened 176 strains isolated from Japan and other Asian countries to determine squalene accumulation using TLC. Among the 176 strains, only 38 were capable of synthesizing high amounts of squalene [55]. In another study, Jiang et al. [53] cultivated three species of S. mangrovei (FB1, FB2, and FB3) on 20 g/L of glucose in flask to study fatty acid composition and squalene content. The highest squalene content of 0.162 mg/gCDW (8.53 g/L CDW) was reported in S. mangrovei FB1. In another study, the same group studied the effect of adding methyl jasmonate (MJA) in the range 0–0.4 mM: addition of 0.1 mM MJA resulted in 1.17 ± 0.006 mg/gCDW of squalene at 48 h of cultivation, or 60% more than in the control [56]. The authors suggested that this result depended on increased squalene synthase activity. However, squalene content in these strains was extremely low compared to that of other thraustochytrids such as Aurantiochytrium sp. 18W-13a, which accumulated 198 mg/gCDW (1.29 ± 0.13 g/L) of squalene at 4 days of cultivation on 20 g/L of glucose, 1% proteose-peptone, and 0.5% yeast extract [47]. In another study, squalene content from the same strain was optimized by varying temperature, salinity, and glucose concentration. Specifically, the highest amount of squalene was 171 mg/gCDW (0.9 g/L) when Aurantiochytrium sp. 18W-13a was cultivated on glucose-peptone-yeast medium containing 20 g/L of glucose with 25 to 50% of seawater at 25 °C [57]. Besides naturally occurring strains, genetic engineering has allowed the construction of strains capable of producing squalene. For example, the oleaginous yeast Yarrowia lipolytica was genetically engineered by deleting the ggs1 gene which was integrated at the YALI0F30987g locus in the CIBTS2112 strain. The ensuing CIBTS2112ΔG strain synthesized 44.5 ± 1.9 mg/gDCW (531.6 ± 25 mg/L) of squalene, a 4.5-fold increase over the parental strain CIBTS2112 [58] or 1.75-fold that of other engineered oleaginous yeast strains [59, 60].

Furthermore, a comprehensive overview of various parameters, including cell dry weight, lipid concentration, lipid content, biomass and lipid yield, their productivity, DHA content and concentration, squalene yield and concentration of Aurantiochytrium sp. T66 cultivated on OPBH in flask or bioreactor is provided in Table 1.

Conclusion

The present study shows that Aurantiochytrium sp. T66 is a promising candidate for commercial DHA production. Importantly, this strain has strong potential to co-synthesize DHA and squalene, which could be more economical for the pharmaceutical and nutraceutical industries. Specifically, the heterotrophic cultivation of Aurantiochytrium sp. T66 on organosolv-pretreated birch hydrolysate instead of pure glucose suggests more economically viable production of nutraceuticals due to consumption of sustainable and cost-effective non-edible lignocellulosic feedstocks. To this end, the highest DHA concentration (2.11 g/L) and DHA content (35.76% w/wtotal lipids) were observed after 96 h of cultivation in a bioreactor. Under these conditions, DHA productivity was 703.33 ± 10.33 mg/L/day and squalene reached a total of 1.0 ± 0.03 g/L (88.47 ± 7.51 mg/gCDW).

Methods

Microalgal strain and cultivation conditions

Aurantiochytrium sp. T66 (ATCC PRA-276) was procured from the American Type Culture Collection (ATCC). Aurantiochytrium sp. T66 was maintained on ATCC 2673 Thraustochytrid medium containing yeast extract (1 g/L), peptone (15 g/L), and glucose (20 g/L) in artificial sea water. The pH of the medium was adjusted to 6.8 before autoclaving. The artificial seawater consisted of (g/L): NaCl, 18; MgSO4·7H2O, 2.44; KCl, 0.6; NaNO3, 1.0; CaCl2·2H2O, 0.3; KH2PO4, 1.0; Tris buffer, 1.0; NH4Cl, 0.027; Vitamin B12, 15 × 10−8; chelated iron solution, 3 mL; and metal solution, 10 mL. The chelated iron solution and metal solution were prepared as described by UTEX Culture Collection of Algae at the University of Texas at Austin [61]. Seed cultures were grown in the aforementioned medium in 250-mL Erlenmeyer flasks with 100 mL of medium and were incubated at 25 °C with continuous shaking at 180 rpm.

Batch cultivation of Aurantiochytrium sp. using organosolv-pretreated birch hydrolysate in flask and bioreactor

Silver birch (Betula pendula L.) was pretreated according to our previously mentioned protocol [36]. Briefly, silver birch wood chips milled to < 1 mm were pretreated in a hybrid organosolv-steam explosion reactor at 200 °C with 60% v/v ethanol and 1% w/wbiomass H2SO4 for 15 min. The pretreated solids were removed from the pretreatment liquor by vacuum filtration, air-dried, and enzymatically saccharified at 10% w/w solids with 20 FPU/gsolids of Cellic CTec2 (Novozymes A/S, Bagsværd, Denmark) in 50 mM citrate–phosphate buffer (pH 5) for 48 h at 50 °C with continuous shaking [36, 37]. At the end of enzymatic saccharification, the remaining solids were removed by centrifugation and the hydrolysate was used for subsequent cultivation trials.

Growth medium was prepared in 50% artificial seawater, by adding the appropriate amount of OPBH to yield 30 g/L of glucose and an appropriate amount of yeast extract to maintain a C:N ratio of 10:1 (g/g) (with yeast extract having 11.6% of total nitrogen, based on the certificate of analysis provided by Sigma-Aldrich, St. Luis, MO, USA). To avoid sugar degradation, an appropriate amount of OPBH in distilled water and seawater containing yeast extract were autoclaved separately and mixed after being cooled to room temperature. The pH of the medium was maintained at 6.8 before autoclaving. Initially, the cultivations were carried out in 250-mL Erlenmeyer flasks containing 100 mL of medium, which was inoculated with 10% v/v of seed culture and incubated at 25 °C and 180 rpm. Time-course experiments were performed by sampling 10 mL of culture every 24 h and were used to determine cell dry weight (g/L), lipid concentration (g/L), lipid content (%, w/w), residual glucose (g/L), DHA concentration (%), and squalene content (mg/gCDW). Thereafter, Aurantiochytrium sp. was cultivated in a 1-L bioreactor (Bio console ADI1025, Applikon Biotechnology, JG Delft, The Netherlands) with 300 mL of OPBH medium (30 g/L of glucose) in 50% artificial seawater and yeast extract (C:Ng/g, 10). The pH was controlled at 6.8 with 3 N NaOH and 3 N HCl and temperature was maintained at 25 °C. During the experiment, dissolved oxygen was maintained above 50% of saturation by sparging with compressed air. Aliquots of 15 mL were sampled every 24 h to estimate residual glucose concentration, cell dry weight, lipid concentration, and squalene concentration.

Estimation of cell dry weight, lipid concentration, and residual glucose in a time-course experiment

To separate the cells from the medium, the samples were centrifuged at 8000 rpm for 10 min. The supernatant was kept for residual sugars determination, whereas the pellet was washed with distilled water to remove media components. The cell pellet was dried in pre-weighed aluminum boats in a hot-air oven at 40 °C until constant weight was attained. Cell dry weight (g/L) was determined gravimetrically. Subsequently, dried biomass was crushed into paste/fine powder by mortar and pastel and mixed with chloroform and methanol (2:1, v/v). The slurry was incubated for 2 h with continuous shaking at room temperature and finally ½ the volume of water was added to the slurry for phase separation. The bottom chloroform layer was aspirated with a pipette in pre-weighed glass vials. Total lipids (g/L) were determined gravimetrically and lipid content (% w/w) was estimated by the following formula;

$${\text{Lipid}}\,{\text{content}} \left( {\% ,\frac{w}{w}} \right) = \left( {{\raise0.7ex\hbox{${{\text{Total}}\,{\text{lipid}}\,{\text{concentration}} }$} \!\mathord{\left/ {\vphantom {{{\text{Total}}\,{\text{lipid}}\,{\text{concentration}} } {{\text{Cell}}\,{\text{dry}}\,{\text{weight}}}}}\right.\kern-0pt} \!\lower0.7ex\hbox{${{\text{Cell}}\,{\text{dry}}\,{\text{weight}}}$}}} \right) \times 100$$

Residual glucose was analyzed on a high-performance liquid chromatographer equipped with an Aminex HPX-87H column (Bio-Rad, Hercules, CA, USA) and a refractive index detector. The column was maintained at 65 °C and 0.6 mL/min of 5 mM H2SO4 was used as the mobile phase.

Extraction and purification of squalene from total lipids

Squalene was extracted from total lipids following the protocol suggested by Nakazawa et al. [55]. Total extracted lipids were hydrolyzed using 0.5 M ethanolic (75%, v/v) KOH solution in a three-necked flask equipped with a reflex condenser at 90 °C for 1 h. The mixture was cooled down at room temperature and non-saponifiable lipids were separated from saponifiable lipids by three rounds of extraction with n-hexane. Total n-hexane was aspirated in a pre-weighed glass vial and evaporated until constant weight was attained. Squalene content (mg/gCDW) was determined gravimetrically.

Determination of squalene by thin-layer chromatography

Total lipids were analyzed for squalene content by TLC on silica gel 60 plates using a mobile phase consisting of n-hexane:diethyl ether:acetic acid (85:15:1; v/v/v). The separated bands were visualized by spraying methanolic MnCl2 solution containing MnCl2·4H2O (0.32 g), water (30 mL), methanol (30 mL), and concentrated H2SO4 (4 mL). The plate was charred in a hot-air oven at 125 °C for 5 min. The squalene band in total lipids was estimated using pure squalene (≥ 98%, liquid, S3626, Sigma-Aldrich) as standard.

Quantification of squalene by high-performance liquid chromatography (HPLC)

A standard stock solution of squalene at 10 mg/mL was prepared with pure squalene in absolute ethanol (≥ 99.8%). The standard calibration curve was prepared using squalene concentrations ranging from 0.001 to 10 mg/mL in acetonitrile. The analysis was performed by HPLC (PerkinElmer, Waltham, MA, USA) using a C18 reverse-phase end-capped chromatography column (NUCLEOSIL® 100-5 C18, 5 µm particles, 100 Å pores, 50 mm, MACHEREY–NAGEL GmbH & Co. KG, Düren, Germany) operating at 30 °C with HPLC-grade acetonitrile:water (9:1, v/v) as mobile phase at a flow rate of 1.5 mL/min with 20 μL of injection volume. The squalene was detected with a UV detector at 210 nm. Samples of lipid-containing squalene were dissolved in 100% acetonitrile.

Estimation of fatty acid profiles and DHA in total extracted lipids

Estimation of the fatty acid profile was carried out after transesterification of extracted lipids using acid catalysts (8 mL of 6% methanolic H2SO4). Fatty acid methyl esters (FAMEs) were extracted with n-hexane and analysis was performed with a GC-FID chromatographer (Agilent, Santa Clara, CA, USA) equipped with a capillary column (Select FAME; dimensions 50 m × 0.25 mm ID and 0.25 μm film thickness). Supelco 37 Component FAME Mix (47885-U, Sigma-Aldrich) was used as a standard to identify the peaks of FAMEs.

Statistical analysis

The experimental values are presented as mean ± standard deviation, with all the trials to be performed in three replicates. Microsoft Office Excel 2016 (Microsoft, USA) was used for one-way analysis of variance (ANOVA) with p < 0.05 for data acceptance.

Availability of data and materials

The materials produced during the current study are available from the corresponding author on reasonable request.

References

  1. 1.

    Ma Y, Gao Z, Wang Q, Liu Y. Biodiesels from microbial oils: opportunity and challenges. Bioresour Technol. 2018;263:631–41.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  2. 2.

    Shields-Menard SA, Amirsadeghi M, French WT, Boopathy R. A review on microbial lipids as a potential biofuel. Bioresour Technol. 2018;259:451–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  3. 3.

    ’t Lam GP, Vermuë MH, Eppink MHM, Wijffels RH, van den Berg C. Multi-product microalgae biorefineries: from concept towards reality. Trends Biotechnol. 2018;36:216–27.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  4. 4.

    Pienkos PT, Darzins A. The promise and challenges of microalgal-derived biofuels. Biofuels Bioprod Biorefin. 2009;3:431–40.

    CAS  Article  Google Scholar 

  5. 5.

    Ratledge C. Fatty acid biosynthesis in microorganisms being used for Single Cell Oil production. Biochimie. 2004;86:807–15.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  6. 6.

    Cho HP, Nakamura M, Clarke SD. Cloning, expression, and fatty acid regulation of the human ∆-5 desaturase cloning, expression, and fatty acid regulation of the human ∆-5 desaturase. J Biol Chem. 1999;274:37335–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  7. 7.

    Jump DB, Depner CM, Tripathy S. Omega-3 fatty acid supplementation and cardiovascular disease. J Lipid Res. 2012;53:2525–45.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. 8.

    Shahidi F, Wanasundara UN. Omega-3 fatty acid concentrates: nutritional aspects and production technologies. Trends Food Sci Technol. 1998;9:230–40.

    CAS  Article  Google Scholar 

  9. 9.

    Rubio-Rodríguez N, Beltrán S, Jaime I, de Diego SM, Sanz MT, Carballido JR. Production of omega-3 polyunsaturated fatty acid concentrates: a review. Innov Food Sci Emerg Technol. 2010;11:1–12.

    Article  CAS  Google Scholar 

  10. 10.

    Somerville C, Browse J. Plant lipids: Metabolism, mutants, and membranes. Science (80-). 1991;252:80–7.

    CAS  Article  Google Scholar 

  11. 11.

    Alonso DL, Maroto FG. Plants as “chemical factories” for the production of polyunsaturated fatty acids. Biotechnol Adv. 2000;18:481–97.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  12. 12.

    Ward OP, Singh A. Omega-3/6 fatty acids: alternative sources of production. Process Biochem. 2005;40:3627–52.

    CAS  Article  Google Scholar 

  13. 13.

    Scheben A, Edwards D. Bottlenecks for genome-edited crops on the road from lab to farm. Genome Biol. 2018;19:178.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  14. 14.

    Beopoulos A, Cescut J, Haddouche R, Uribelarrea J-L, Molina-Jouve C, Nicaud J-M. Yarrowia lipolytica as a model for bio-oil production. Prog Lipid Res. 2009;48:375–87.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  15. 15.

    Beopoulos A, Nicaud JM. Yeast: a new oil producer? OCL—Ol Corps Gras Lipides. 2012;19:22–8.

    Article  Google Scholar 

  16. 16.

    Ratledge C. Microbial oils: an introductory overview of current status and future prospects. OCL. 2013;20:D602.

    Article  Google Scholar 

  17. 17.

    Raghukumar S. Thraustochytrid marine protists : production of PUFAs and other emerging technologies. Mar Biotechnol. 2008;10:631–40.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Selvaraj M, Kumar TS, Rao MV. Squalene, biosynthesis and its role in production of bioactive compounds, a proper scientific challenge—a review. J Emerg Technol Innov Res. 2019;6:505–26.

    Google Scholar 

  19. 19.

    Xu W, Ma X, Wang Y. Production of squalene by microbes: an update. World J Microbiol Biotechnol. 2016;32:195.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  20. 20.

    Pollier J, Vancaester E, Kuzhiumparambil U, Vickers CE, Vandepoele K, Goossens A, et al. A widespread alternative squalene epoxidase participates in eukaryote steroid biosynthesis. Nat Microbiol. 2019;4:226–33.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  21. 21.

    Kilincalp S, Deveci M, Basar O, Ekiz F, Coban S, Yuksel O. Shark liver oil: hidden dangers. Ann Hepatol. 2012;11:728–30.

    PubMed  Article  PubMed Central  Google Scholar 

  22. 22.

    Storelli MM, Ceci E, Storelli A, Marcotrigiano GO. Polychlorinated biphenyl, heavy metal and methylmercury residues in hammerhead sharks: contaminant status and assessment. Mar Pollut Bull. 2003;46:1035–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  23. 23.

    Güneş FE. Medical use of squalene as a natural antioxidant. J Marmara Univ Inst Heal Sci. 2013;3:220–8.

    Google Scholar 

  24. 24.

    Garcia-Bermudez J, Baudrier L, Bayraktar EC, Shen Y, La K, Guarecuco R, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567:118–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  25. 25.

    Brown AJ, Chua NK, Yan N. The shape of human squalene epoxidase expands the arsenal against cancer. Nat Commun. 2019;10:2–5.

    Article  CAS  Google Scholar 

  26. 26.

    Reddy LH, Couvreur P. Squalene: a natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev. 2009;61:1412–26.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  27. 27.

    Gohil N, Bhattacharjee G, Khambhati K, Braddick D, Singh V. Engineering Strategies in Microorganisms for the Enhanced Production of Squalene: advances, challenges and opportunities. Front Bioeng Biotechnol. 2019;7:1–24.

    Article  Google Scholar 

  28. 28.

    Oya SI, Kanno D, Watanabe H, Tamura M, Nakagawa Y, Tomishige K. Catalytic production of branched small alkanes from biohydrocarbons. Chemsuschem. 2015;8:2472–5.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  29. 29.

    Zhang K, Zhang X, Tan T. The production of bio-jet fuel from: botryococcus braunii liquid over a Ru/CeO2 catalyst. RSC Adv R Soc Chem. 2016;6:99842–50.

    CAS  Article  Google Scholar 

  30. 30.

    Rosales-Garcia T, Jimenez-Martinez C, Davila-Ortiz G. Squalene extraction: biological sources and extraction methods. Int J Environ Agric Biotechnol. 2017;2:1662–70.

    Article  Google Scholar 

  31. 31.

    Popa O, Bəbeanu NE, Popa I, Niţə S, Dinu-Pârvu CE. Methods for obtaining and determination of squalene from natural sources. Biomed Res Int. 2015;2015:16.

    Article  CAS  Google Scholar 

  32. 32.

    Xie Y, Sen B, Wang G. Mining terpenoids production and biosynthetic pathway in thraustochytrids. Bioresour Technol. 2017;244:1269–80.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  33. 33.

    Liu B, Ertesvåg H, Aasen IM, Vadstein O, Brautaset T, Heggeset TMB. Draft genome sequence of the docosahexaenoic acid producing thraustochytrid Aurantiochytrium sp. T66. Genomics Data. 2016;8:115–6.

    PubMed  PubMed Central  Article  Google Scholar 

  34. 34.

    Hong WK, Rairakhwada D, Seo PS, Park SY, Hur BK, Kim CH, et al. Production of lipids containing high levels of docosahexaenoic acid by a newly isolated microalga, Aurantiochytrium sp. KRS101. Appl Biochem Biotechnol. 2011;164:1468–80.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Nakazawa A, Matsuura H, Kose R, Ito K, Ueda M, Honda D, et al. Optimization of biomass and fatty acid production by Aurantiochytrium sp. strain 4W-1b. Procedia Environ Sci. 2012;15:27–33.

    CAS  Article  Google Scholar 

  36. 36.

    Matsakas L, Nitsos C, Raghavendran V, Yakimenko O, Persson G, Olsson E, et al. A novel hybrid organosolv—steam explosion method for the efficient fractionation and pretreatment of birch biomass. Biotechnol Biofuels. 2018;11:1–14.

    Article  CAS  Google Scholar 

  37. 37.

    Patel A, Matsakas L, Rova U, Christakopoulos P. Heterotrophic cultivation of Auxenochlorella protothecoides using forest biomass as a feedstock for sustainable biodiesel production. Biotechnol Biofuels. 2018;11:169.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  38. 38.

    Bumbak F, Cook S, Zachleder V, Hauser S, Kovar K. Best practices in heterotrophic high-cell-density microalgal processes: achievements, potential and possible limitations. Appl Microbiol Biotechnol. 2011;91:31–46.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  39. 39.

    Nazir Y, Shuib S, Kalil MS, Song Y, Hamid AA. Optimization of culture conditions for enhanced growth, lipid and docosahexaenoic acid (DHA) production of Aurantiochytrium SW1 by response surface methodology. Sci Rep. 2018;8:1–12.

    Article  CAS  Google Scholar 

  40. 40.

    Gao M, Song X, Feng Y, Li W, Cui Q. Isolation and characterization of Aurantiochytrium species: high docosahexaenoic acid (DHA) production by the newly isolated microalga, Aurantiochytrium sp. SD116. J Oleo Sci. 2013;62:143–51.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  41. 41.

    Safdar W, Zan X, Song Y. Synergistic effect of phosphorus and nitrogen on growth, lipid accumulation and docosahexaenoic acid production in Crypthecodinium Cohnii. Int J Agric Innov Res. 2017;5:768–75.

    Google Scholar 

  42. 42.

    Chang G, Luo Z, Gu S, Wu Q, Chang M, Wang X. Fatty acid shifts and metabolic activity changes of Schizochytrium sp. S31 cultured on glycerol. Bioresour Technol. 2013;142:255–60.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  43. 43.

    Gupta A, Barrow CJ, Puri M. Omega-3 biotechnology: thraustochytrids as a novel source of omega-3 oils. Biotechnol Adv. 2012;30:1733–45.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  44. 44.

    Furlan VJM, Maus V, Batista I, Bandarra NM. Production of docosahexaenoic acid by Aurantiochytrium sp. ATCC PRA-276. Braz J Microbiol Sociedade Brasileira de Microbiol. 2017;48:359–65.

    CAS  Article  Google Scholar 

  45. 45.

    Wu ST, Yu ST, Lin LP. Effect of culture conditions on docosahexaenoic acid production by Schizochytrium sp. S31. Process Biochem. 2005;40:3103–8.

    CAS  Article  Google Scholar 

  46. 46.

    Papanikolaou S, Sarantou S, Komaitis M, Aggelis G. Repression of reserve lipid turnover in Cunninghamella echinulata and Mortierella isabellina cultivated in multiple-limited media. J Appl Microbiol. 2004;97:867–75.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  47. 47.

    Kaya K, Nakazawa A, Matsuura H, Honda D, Inouye I, Watanabe MM. Thraustochytrid Aurantiochytrium sp. 18W-13a accummulates high amounts of squalene. Biosci Biotechnol Biochem. 2011;75:2246–8.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. 48.

    Barclay WR, Meager KM, Abril JR. Heterotrophic production of long chain omega-3 fatty acids utilizing algae and algae-like microorganisms. J Appl Phycol. 1994;6:123–9.

    CAS  Article  Google Scholar 

  49. 49.

    Wu ST, Lin LP. Application of response surface methodology to optimize docosahexaenoic acid production by Schizochytrium sp. S31. J Food Biochem. 2003;27:127–39.

    CAS  Article  Google Scholar 

  50. 50.

    Wu K, Ding L, Zhu P, Li S, He S. Application of the response surface methodology to optimize the fermentation parameters for enhanced docosahexaenoic acid (DHA) production by Thraustochytrium sp. ATCC 26185. Molecules. 2018;23:974.

    PubMed Central  Article  CAS  Google Scholar 

  51. 51.

    Iida I, Nakahara T, Yokochi T, Kamisaka Y, Yagi H, Yamaoka M, et al. Improvement of docosahexaenoic acid production in a culture of Thraustochytrium aureum by medium optimization. J Ferment Bioeng. 1996;81:76–8.

    CAS  Article  Google Scholar 

  52. 52.

    Nakahara T, Yokochi T, Higashihara T, Tanaka S, Yaguchi T, Honda D. Production of docosahexaenoic and docosapentaenoic acids by Schizochytrium sp. isolated from yap islands. JAOCS J Am Oil Chem Soc. 1996;73:1421–6.

    CAS  Article  Google Scholar 

  53. 53.

    Jiang Y, Fan K-W, Tsz-Yeung Wong R, Chen F. Fatty acid composition and squalene content of the marine microalga Schizochytrium mangrovei. J Agric Food Chem. 2004;52:1196–200.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  54. 54.

    Aki T, Hachida K, Yoshinaga M, Katai Y, Yamasaki T, Kawamoto S, et al. Thraustochytrid as a potential source of carotenoids. JAOCS J Am Oil Chem Soc. 2003;80:789–94.

    CAS  Article  Google Scholar 

  55. 55.

    Nakazawa A, Kokubun Y, Matsuura H, Yonezawa N, Kose R, Yoshida M, et al. TLC screening of thraustochytrid strains for squalene production. J Appl Phycol. 2014;26:29–41.

    CAS  Article  Google Scholar 

  56. 56.

    Yue CJ, Jiang Y. Impact of methyl jasmonate on squalene biosynthesis in microalga Schizochytrium mangrovei. Process Biochem. 2009;44:923–7.

    CAS  Article  Google Scholar 

  57. 57.

    Nakazawa A, Matsuura H, Kose R, Kato S, Honda D, Inouye I, et al. Optimization of culture conditions of the thraustochytrid Aurantiochytrium sp. strain 18W-13a for squalene production. Bioresour Technol. 2012;109:287–91.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  58. 58.

    Gao S, Tong Y, Zhu L, Ge M, Zhang Y, Chen D, et al. Iterative integration of multiple-copy pathway genes in Yarrowia lipolytica for heterologous β-carotene production. Metab Eng. 2017;41:192–201.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  59. 59.

    Ghimire GP, Hei CL, Jae KS. Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. Appl Environ Microbiol. 2009;75:7291–3.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Rasool A, Zhang G, Li Z, Li C. Engineering of the terpenoid pathway in Saccharomyces cerevisiae co-overproduces squalene and the non-terpenoid compound oleic acid. Chem Eng Sci. 2016;152:457–67.

    CAS  Article  Google Scholar 

  61. 61.

    Artificial Seawater Medium Recipe. p. 1. https://utex.org/products/artificial-seawater-medium. Accessed 28 Sept 2019.

  62. 62.

    Park WK, Moon M, Shin SE, Cho JM, Suh WI, Chang YK, et al. Economical DHA (docosahexaenoic acid) production from Aurantiochytrium sp. KRS101 using orange peel extract and low cost nitrogen sources. Algal Res. 2018;29:71–9.

    Article  Google Scholar 

  63. 63.

    Patil KP, Gogate PR. Improved synthesis of docosahexaenoic acid (DHA) using Schizochytrium limacinum SR21 and sustainable media. Chem Eng J. 2015;268:187–96.

    CAS  Article  Google Scholar 

  64. 64.

    Chen G, Fan KW, Lu FP, Li Q, Aki T, Chen F, et al. Optimization of nitrogen source for enhanced production of squalene from thraustochytrid Aurantiochytrium sp. N Biotechnol. 2010;27:382–9.

    CAS  PubMed  Article  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Sveaskog, Sweden, for providing the birch and spruce chips that were used in this study, Novozymes A/S, Denmark and for providing the Cellic® CTec2 enzyme solution. We would like to acknowledge Kentaro Umeki and Albert Bach Oller from Energy Engineering, Division of Energy Science, Department of Engineering Sciences and Mathematics, Luleå University of Technology, Luleå, Sweden for providing the GC-FID apparatus.

Funding

The authors will like to thank Bio4Energy, a strategic research environment appointed by the Swedish government, and Kempe Foundations, for supporting this work.

Author information

Affiliations

  1. Biochemical Process Engineering, Division of Chemical Engineering, Department of Civil, Environmental, and Natural Resources Engineering, Luleå University of Technology, 971 87, Luleå, Sweden

    Alok Patel, Ulrika Rova, Paul Christakopoulos & Leonidas Matsakas

Authors
  1. Alok Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ulrika Rova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Christakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Leonidas Matsakas
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AP: Conceived the study, performed the experimental and analytical work, analyzed the data and drafted the manuscript. UR: Conceived the study and participated in experimental design and data analysis. PC: Conceived the study and participated in experimental design and data analysis. LM: Conceived the study, participated in the experimental design, analyzed the data and performed the organosolv pretreatment. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Leonidas Matsakas.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Patel, A., Rova, U., Christakopoulos, P. et al. Simultaneous production of DHA and squalene from Aurantiochytrium sp. grown on forest biomass hydrolysates. Biotechnol Biofuels 12, 255 (2019). https://doi.org/10.1186/s13068-019-1593-6

Download citation

Keywords

  • Thraustochytrids
  • Aurantiochytrium sp.
  • DHA
  • Squalene
  • Wood biomass
  • Organosolv pretreatment
  • Heterotrophic growth
  • Lipid production

Biotechnology for Biofuels

ISSN: 1754-6834

Contact us